Biomarkers of Response and Resistance to Immunotherapy in Microsatellite Stable Colorectal Cancer: Toward a New Personalized Medicine

SIMPLE SUMMARY: Immune Checkpoint Inhibitors (ICIs) have demonstrated clinical efficacy in Microsatellite Instability High Colorectal Cancer (MSI-H CRC). However, in Microsatellite Stable (MSS) CRC, ICIs monotherapy provides limited clinical benefit. Therefore, efforts must be made to understand the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huyghe, Nicolas, Benidovskaya, Elena, Stevens, Philippe, Van den Eynde, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105843/
https://www.ncbi.nlm.nih.gov/pubmed/35565369
http://dx.doi.org/10.3390/cancers14092241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105843/
https://www.ncbi.nlm.nih.gov/pubmed/35565369
http://dx.doi.org/10.3390/cancers14092241

Ejemplares similares